Neeltje A. Kootstra

University of Amsterdam - Amsterdam Institute for Infection and Immunity

SCHOLARLY PAPERS

2

DOWNLOADS

231

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

The Effect of SARS-CoV-2 Vaccination on Post-Acute COVID-19 Syndrome (PACS): A Prospective Cohort Study

Number of pages: 32 Posted: 31 Jan 2022
Public Health Service of Amsterdam - Department of Infectious Diseases, University of Amsterdam - Department of Medical Microbiology & Infection Prevention, Public Health Service of Amsterdam - Department of Infectious Diseases, Amsterdam University Medical Centre, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Public Health Research Institute, Amsterdam University Medical Centres, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Public Health Service of Amsterdam - Department of Infectious Diseases, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Amsterdam Public Health Research Institute, Public Health Service of Amsterdam - Department of Infectious Diseases and affiliation not provided to SSRN
Downloads 171 (278,410)
Citation 1

Abstract:

Loading...

COVID-19, vaccination, long COVID, post-acute COVID-19 syndrome, symptoms

2.

Fourth mRNA COVID-19 Vaccination in Immunocompromised Patients with Hematologic Malignancies

Number of pages: 23 Posted: 06 Mar 2023
University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam - Department of Clinical Epidemiology, Biostatistics and Bioinformation, Erasmus University Rotterdam (EUR) - Department of Hematology, University of Groningen - Department of Hematology and Oncology, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), National Institute for Public Health and the Environment (RIVM) - Department of Immune Surveillance, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Vrije Universiteit Amsterdam - Department of Hematology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Amsterdam Institute for Infection and Immunity, National Institute of Public Health and the Environment, University of Amsterdam - Central Diagnostic Laboratory, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Free University, Amsterdam - Medical Immunology Laboratory, University of Amsterdam - Amsterdam Institute for Infection and Immunity, Netherlands Comprehensive Cancer Organisation, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM) - Department for Immunology of Infectious Diseases and Vaccination (IIV), Leiden University, Medical Center (LUMC), Department of Hematology, Vrije Universiteit Amsterdam - Department of Hematology, University of Groningen - Department of Hematology and Oncology, Erasmus University Rotterdam (EUR) - Department of Hematology, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Infectious Diseases, University of Amsterdam, Academic Medical Center, Department of Hematology, University of Amsterdam, Academic Medical Center, Department of Hematology, Vrije Universiteit Amsterdam - Department of Hematology and Independent
Downloads 60 (562,975)

Abstract:

Loading...

Humoral immunogenicity, Antibody response, SARS-CoV-2, COVID-19 vaccination, Booster vaccination, Hematologic malignancies, Immunocompromised